Novanta NOVT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Automation Enabling Technologies | $131.24M+6.6% | $130.68M+2.3% | $125.32M-2.6% | $121.67M+4.2% | $123.17M+4.9% | |
| Medical Solutions | $126.46M+14.8% | $127.67M+15.8% | $122.52M+5.9% | $119.38M+0.2% | $110.2M-2.9% | |
| Robotics And Automation | $84.17M+7.1% | $82.02M+5.6% | $80.14M+0.1% | $77.84M+15.5% | $78.59M+24.3% | |
| Segment Operating Income by Business | ||||||
| Automation Enabling Technologies | $31.15M-1.1% | $28.82M-6.7% | $27.35M-9.0% | $26.87M+24.9% | $31.49M+31.6% | |
| Medical Solutions | $16.73M+19.2% | $14.6M+107% | $15.92M-2.5% | $6.63M-63.5% | $14.03M-12.4% | |
| Gross Profit by Business | ||||||
| Automation Enabling Technologies | $62.75M+5.7% | $62.7M-1.9% | $59.21M-2.2% | $58.21M+5.8% | $59.39M+7.0% | |
| Medical Solutions | $52.18M+13.5% | $51.53M+14.6% | $52.7M+6.6% | $49.51M+0.4% | $45.96M-0.6% | |
| Accounts Receivable Net Current by Business | ||||||
| Automation Enabling Technologies | $80.67M+3.8% | $76.69M+8.3% | $73.25M— | $66.16M— | $77.73M— | |
| Medical Solutions | $93.26M+7.8% | $108.2M+34.9% | $97.31M— | $95.04M— | $86.48M— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | ||||||
| Automation Enabling Technologies | $31.15M-1.1% | $28.82M-6.7% | $27.35M-9.0% | $26.87M+24.9% | $31.49M+31.6% | |
| Medical Solutions | $16.73M+19.2% | $14.6M+107% | $15.92M-2.5% | $6.63M-63.5% | $14.03M-12.4% | |
| Inventory Net by Business | ||||||
| Automation Enabling Technologies | $114.54M+27.3% | $110.21M+23.8% | $101.2M— | $96.05M— | $90M— | |
| Medical Solutions | $78.6M+41.8% | $78.08M+40.4% | $78.78M— | $72.02M— | $55.43M— | |
| Selling General And Administrative Expense by Business | ||||||
| Automation Enabling Technologies | $19.89M+3.8% | $20.27M+1.3% | $18.55M+3.0% | $18.33M-3.0% | $19.16M+3.6% | |
| Medical Solutions | $16.31M+10.7% | $15.48M+14.0% | $14.76M+7.1% | $15.06M+17.5% | $14.73M+8.1% | |
| Restructuring Costs by Business | ||||||
| Automation Enabling Technologies | $586K+20.6% | -$5.23M-1,843% | $694K-14.2% | $940K-48.1% | $486K+74.2% | |
| Medical Solutions | $506K+517% | $633K-87.7% | $2.49M+140% | $4.2M+1,067% | $82K-60.2% | |
| Unallocated | $178K+709% | —— | $1.08M+1,375% | $1.69M+380% | $22K-65.1% | |
| Cost of Goods Sold by Business | ||||||
| Automation Enabling Technologies | $67.29M+7.8% | $66.57M+6.8% | $64.63M-2.9% | $62.14M+3.3% | $62.42M+3.5% | |
| Medical Solutions | $71.73M+15.6% | $73.3M+16.0% | $67.04M+4.5% | $66.97M-1.0% | $62.04M-4.8% | |
| D&A by Business | ||||||
| Automation Enabling Technologies | $4.2M-23.3% | $5.71M-7.3% | $5.81M-3.0% | $5.45M-7.2% | $5.48M-6.5% | |
| Medical Solutions | $9.58M+24.7% | $11.01M+43.2% | $9.53M+23.4% | $9.75M+24.7% | $7.68M+16.4% | |
| Goodwill Gross by Business | ||||||
| Automation Enabling Technologies | $445.98M+3.1% | $447.31M+1.7% | $447.38M— | $447.76M— | $432.46M— | |
| Medical Solutions | $348.62M+13.3% | $351.26M+18.9% | $351.36M+27.0% | $352.56M+28.7% | $307.82M+11.2% | |
| Amortization Of Intangible Assets by Business | ||||||
| Automation Enabling Technologies | $2.12M-12.0% | $2.46M-12.2% | $2.56M-8.9% | $2.35M-16.1% | $2.41M-14.0% | |
| Medical Solutions | $3.66M+16.2% | $5.67M+51.1% | $4.37M+15.6% | $4.52M+10.0% | $3.15M+6.7% | |
| Research And Development Expense by Business | ||||||
| Automation Enabling Technologies | $9.03M-4.3% | $9.46M-7.2% | $9.64M+8.8% | $9.27M-7.1% | $9.44M-5.6% | |
| Medical Solutions | $14.25M+2.1% | $13.59M-11.9% | $14.63M+0.7% | $16.17M+16.3% | $13.96M+5.2% | |
| Restructuring Charges And Acquisition Related Costs by Business | ||||||
| Automation Enabling Technologies | $563K+118% | $1.7M+9,339% | $1.11M+37.1% | $1.39M-23.5% | -$3.11M-1,214% | |
| Medical Solutions | $1.24M+1,153% | $2.18M-57.8% | $3.04M+193% | $7.13M+1,876% | $99K-73.0% | |
| Cost Of Goods And Services Sold Amortization by Business | ||||||
| Automation Enabling Technologies | $1.2M-11.6% | $1.41M-10.0% | $1.47M-6.8% | $1.33M-15.1% | $1.36M-13.4% | |
| Medical Solutions | $2.56M+16.2% | $2.84M+33.7% | $2.78M+30.6% | $2.89M+36.4% | $2.2M+3.7% | |
| Goodwill Impaired Accumulated Impairment Loss by Business | ||||||
| Automation Enabling Technologies | $119.51M0.0% | $119.51M0.0% | $119.51M— | $119.51M— | $119.51M— | |
| Medical Solutions | $31.72M0.0% | $31.72M0.0% | $31.72M0.0% | $31.72M0.0% | $31.72M0.0% | |
| Goodwill by Business | ||||||
| Automation Enabling Technologies | $326.48M+4.3% | $327.81M+2.3% | $327.88M— | $328.26M— | $312.95M— | |
| Medical Solutions | $316.9M+14.8% | $319.54M+21.2% | $319.64M+30.5% | $320.84M+32.4% | $276.1M+12.7% | |
| Revenue by Geography | ||||||
| CN | $23.55M+9.9% | $25.7M+7.7% | $24.29M-1.3% | $21.78M+14.5% | $21.43M+25.6% | |
| DE | $36.29M+27.5% | $31.82M+29.4% | $27.1M-19.3% | $27.26M-14.6% | $28.48M-14.2% | |
| Other Countries | $6.22M+33.8% | $5.34M+2.7% | $4.93M+18.4% | $4.38M+19.1% | $4.65M-13.2% | |
| Rest Of Asia Pacific | $27.39M+17.2% | $24.56M-10.1% | $24.43M-10.0% | $24.67M-2.6% | $23.38M-14.2% | |
| Rest Of Europe | $42.24M+32.9% | $34.12M-1.9% | $36.66M+19.9% | $34.85M+7.1% | $31.78M+2.6% | |
| US | $122.01M-1.3% | $136.82M+11.9% | $130.42M+4.9% | $128.12M+3.8% | $123.65M+5.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Novanta break its business down?
- Novanta (NOVT) reports revenue by business across 3 parts — Automation Enabling Technologies, Medical Solutions and Robotics And Automation. Each is extracted from the segment footnotes and tracked over time.
- Where does Novanta's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Novanta's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.